当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析 - 现金流量表

灵康药业

(603669)

  

流通市值:38.66亿  总市值:38.66亿
流通股本:7.21亿   总股本:7.21亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金176,565,565.6937,359,969.68235,291,466.02238,867,039.41
  收到其他与经营活动有关的现金19,825,375.06526,291.9847,237,60734,680,716.93
  经营活动现金流入小计196,390,940.7537,886,261.66282,529,073.02273,547,756.34
  购买商品、接受劳务支付的现金117,119,438.7813,243,955.39208,548,318.97206,756,300.58
  支付给职工以及为职工支付的现金27,541,748.615,935,507.2647,790,751.1536,462,803.02
  支付的各项税费12,307,224.8810,074,437.217,917,388.895,396,553.34
  支付其他与经营活动有关的现金78,382,437.3912,202,323.4129,161,372.488,988,774.03
  经营活动现金流出小计235,350,849.6551,456,223.26393,417,831.41337,604,430.97
  经营活动产生的现金流量净额-38,959,908.9-13,569,961.6-110,888,758.39-64,056,674.63
二、投资活动产生的现金流量:
  收回投资收到的现金9,689,834.21---
  取得投资收益收到的现金1,114,006.218,501.178,098,888.522,629,299.48
  处置固定资产、无形资产和其他长期资产收回的现金净额191,000152,0002,067,6001,915,600
  收到的其他与投资活动有关的现金17,332,76217,332,762367,000,000192,000,000
  投资活动现金流入小计28,327,602.4217,493,263.17377,166,488.52196,544,899.48
  购建固定资产、无形资产和其他长期资产支付的现金825,650.02543,497.568,847,836.798,907,467.49
  支付其他与投资活动有关的现金--2,532,7622,532,762
  投资活动现金流出小计825,650.02543,497.5611,380,598.7911,440,229.49
  投资活动产生的现金流量净额27,501,952.416,949,765.61365,785,889.73185,104,669.99
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金252,008,404.392,008,404.39220,036,467.43222,004,918.6
  筹资活动现金流入小计252,008,404.392,008,404.39220,036,467.43222,004,918.6
  偿还债务支付的现金1,008.25-322,178,500117,352,500
  分配股利、利润或偿付利息支付的现金--5,729,920.06203,729.57
  支付其他与筹资活动有关的现金250,000,000-214,206,515.01418,736,729.43
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计250,001,008.25-542,114,935.07536,292,959
  筹资活动产生的现金流量净额2,007,396.142,008,404.39-322,078,467.64-314,288,040.4
五、现金及现金等价物净增加额-9,450,560.365,388,208.4-67,181,336.3-193,240,045.04
  加:期初现金及现金等价物余额247,269,420.52247,269,420.52314,450,756.82314,450,756.82
  期末现金及现金等价物余额237,818,860.16252,657,628.92247,269,420.52121,210,711.78
补充资料:
  净利润-35,733,685.77--130,763,688.85-
  资产减值准备107,822.6-32,296,796.18-
  固定资产和投资性房地产折旧11,781,614.91-26,714,779.22-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,781,614.91-26,714,779.22-
  无形资产摊销3,438,427.45-7,287,065.72-
  长期待摊费用摊销1,443,838.73-3,474,385.14-
  处置固定资产、无形资产和其他长期资产的损失49,322.73--83,625.67-
  固定资产报废损失206,027.62-93,928.87-
  公允价值变动损失347,222.93-1,862,431.19-
  财务费用10,272,529.67--4,925,154.54-
  投资损失3,046,508.71-12,723,355.72-
  递延所得税-232,533.66-1,563,557.75-
  其中:递延所得税资产减少--2,198,900.92-
    递延所得税负债增加-232,533.66--635,343.17-
  存货的减少-21,021,707.83-26,262,210.64-
  经营性应收项目的减少1,751,629.05--201,431,637.27-
  经营性应付项目的增加-19,273,933.27-92,927,368.23-
  其他-70,978.48---
  现金的期末余额237,818,860.16-247,269,420.52-
  减:现金的期初余额247,269,420.52-314,450,756.82-
  现金及现金等价物的净增加额-9,450,560.36--67,181,336.3-
公告日期2025-08-232025-04-262025-04-192024-10-31
审计意见(境内)标准无保留意见
TOP↑